General Information of Drug (ID: DM6V4I3)

Drug Name
AMP-110
Indication
Disease Entry ICD 11 Status REF
Autoimmune diabetes 5A10 Phase 1 [1]
Cross-matching ID
TTD ID
D0B5TM

References

1 ClinicalTrials.gov (NCT01878123) Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health.